arrow
W

Wenya Linda Bi

department of neuro surgery
H指数:59
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reassessing the Management of Treatment-Induced Brain Necrosis in Metastatic Patients: Advancing Surgical Alternatives to Steroid Therapy

重新评估转移性患者治疗相关性脑坏死的管理:推进手术替代方案以取代类固醇疗法

2025-12-010
PRE
SAFETY AND TOLERABILITY OF OLAPARIB, TEMOZOLOMIDE, AND PEMBROLIZUMAB IN A PHASE 2 TRIAL IN PATIENTS WITH PROGRESSIVE GLIOBLASTOMA

奥拉帕利、替莫唑胺和帕博利珠单抗在进展性胶质母细胞瘤患者中的II期试验的安全性与耐受性

2025-11-010
OAAI
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells

间皮素是一种存在于人类脑膜瘤表面的抗原,并且可以被CAR T细胞有效靶向。

2025-11-010
OAAI
SCHWANNOMAS DISPLAY CONSERVED CELLULAR STATES AND PREFERENTIAL MHC CLASS II ANTIGEN PRESENTATION ACROSS DIFFERENT GENETIC BACKGROUNDS AND ANATOMIC LOCATIONS

神经鞘瘤表现出保守的细胞状态,并在不同的遗传背景和解剖位置上表现出对MHC II类抗原的优先呈递。

2025-10-010
OA
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis

TERT启动子突变对预测脑膜瘤预后的影响:一项多中心队列分析

2025-09-010
PRE
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells

Ramapriyan, R.; Barker, F.G., 2nd; Richardson, L.G.; Sun, J.; Vandecandelaere, G.; Shim, J.M.; De Vlaminck, G.; Gaffey, M.; Grewal, E.P.; Tazhibi, M.; et al. 纤维蛋白是存在于人类脑膜瘤表面的抗原,并且可以被CAR T细胞有效靶向。Neuro-Oncology 2025, noaf155. [Google Scholar] [CrossRef]

2025-07-015
PRE
Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4

新诊断的IDH突变型WHO 4级星形细胞瘤的预后临床、分子和放射学预测因子

2025-07-010
PRE
Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation-A progress report

神经肿瘤学反应评估(RANO)2009–2025:广泛范围与实施——进展报告

2025-06-012
PRE
RETRACTION: Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells

撤稿:目标受体鉴定及后续治疗:使用封装和工程化异体干细胞治疗切除的脑肿瘤

2025-03-210
OA